ONO completes acquisition of Deciphera Pharmaceuticals to reinforce its oncology portfolio
Acquiring Company
ONO Pharmaceutical Ltd
Acquired Company
Deciphera Pharmaceuticals
Osaka
WalthamBiotechnologyHealth CarePharmaceuticalBiotechnologyHealthcareHealth CareTherapeuticsDescription
ONO Pharmaceutical, Co., Ltd., based in OSAKA, Japan, has entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. This strategic acquisition reinforces ONO's commitment to delivering innovative new drugs to patients around the world, strengthens its oncology portfolio, and accelerates its business development in the United States and Europe. The acquisition will also enhance ONO's pipeline and research and development capabilities in the field of oncology.
Quick answer
ONO Pharmaceutical Ltd is acquiring Deciphera Pharmaceuticals, announced April 30, 2024. ONO Pharmaceutical Ltd is based in Osaka, Osaka Prefecture, Japan.
- How much did ONO Pharmaceutical Ltd pay for Deciphera Pharmaceuticals?
- The deal value was not disclosed.
- What does ONO Pharmaceutical Ltd do?
- ONO Pharmaceutical, Co., Ltd. is a Global Specialty Pharma company focused on delivering innovative new drugs to patients around the world.
- Where are ONO Pharmaceutical Ltd and Deciphera Pharmaceuticals based?
- ONO Pharmaceutical Ltd is based in Osaka, Osaka Prefecture, Japan. Deciphera Pharmaceuticals is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at ONO Pharmaceutical Ltd?
- Fundz holds 1 contact at ONO Pharmaceutical Ltd. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- ONO Pharmaceutical Co., Ltd. to acquire Deciphera Pharmaceuticals, Inc. for $2.4 Billion, $2.4B (April 29, 2024)
Who to call at ONO Pharmaceutical Ltd, and when
When ONO Pharmaceutical Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ONO Pharmaceutical Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ONO Pharmaceutical Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ONO Pharmaceutical Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ONO Pharmaceutical Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals was acquired by ONO Pharmaceutical Ltd, based in Osaka. The deal was reported on April 30, 2024. ONO Pharmaceutical, Co., Ltd. is a Global Specialty Pharma company focused on delivering innovative new drugs to patients around the world. ONO Pharmaceutical Ltd is privately held and operates in Biotechnology.
When did ONO Pharmaceutical Ltd acquire Deciphera Pharmaceuticals?
ONO Pharmaceutical Ltd's acquisition of Deciphera Pharmaceuticals was reported on April 30, 2024. ONO Pharmaceutical, Co., Ltd., based in OSAKA, Japan, has entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Deciphera Pharmaceuticals do?
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. It is privately held, operating in Biotechnology, and is based in Waltham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.